Insider Buys at Tango Therapeutics Signal Confidence in Rare‑Disease Pipeline
Insider buys at Tango Therapeutics signal confidence in its rare‑disease pipeline, highlighting strategic alliances, orphan‑drug advantages and a bullish outlook for investors.
4 minutes to read